← FDA Drug Approvals (Drugs@FDA)
TYSABRI
BLA · Biologics License Application · Sponsor: BIOGEN IDEC · Approved 2004-11-23
Drug application
- FDA Application #
BLA125104- Application type
- Biologics License Application
- Brand name
- TYSABRI
- Generic name
- NATALIZUMAB
- Active ingredients
- NATALIZUMAB
- Dosage form
- VIAL
- Route
- SINGLE-USE
- Marketing status
- Prescription
- Sponsor
- BIOGEN IDEC
- Manufacturer
- Biogen Inc.
- First approval
- 2004-11-23
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown